Ashraf Amanullah
Advertisement
Ashraf Amanullah is a director at Oceanside Pharma Technical Development, Genentech, Inc.
Articles by Ashraf Amanullah
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Caldera’s IL-23p19×TL1A Bispecific CLD-423 Shows 40-Day Half-Life in Phase 1a, Supporting Dosing Every 8 to 12 Weeks
2
China Grants Ivonescimab Priority Review in Biliary Tract Cancer
3
FAQ: What FDA’s Individualized Gene Editing Draft Guidance Means for Developers
4
VeonGen Aligns with FDA on Phase 3 Design for Stargardt Gene Therapy
5